@techreport{10665-338849,
  author    = {Organización Mundial de la Salud},
  title     = {{Recomendaciones provisionales para utilizar la vacuna contra la COVID-19 elaborada por Pfizer y BioNTech, BNT162b2, en el marco de la lista de uso en emergencias: orientaciones provisionales, 8 de enero de 2021}},
  year      = {2021},
  publisher = {Organización Mundial de la Salud},
  url       = {https://iris.who.int/handle/10665/338849},
}

@misc{10665-338849.sec-034.1,
  year = {2021},
  url  = {https://www.who.int/news-room/events/detail/2021/01/05/default-calendar/extraordinary-meeting-of-the-strategic-advisory-group-of-experts-on-immunization-(sage)---5-january-2021},
}

@misc{10665-338849.sec-034.2,
  year = {2017},
  url  = {https://www.who.int/immunization/sage/Guidelines_development_recommendations.pdf},
}

@misc{10665-338849.sec-034.3,
  year = {2020},
  url  = {https://www.who.int/publications/i/item/WHO-2019-nCoV-SAGE-Framework-Evidence-2020-1},
}

@misc{10665-338849.sec-034.4,
  year = {2020},
  url  = {https://www.who.int/es/publications/m/item/who-sage-roadmap-for-prioritizing-uses-of-covid-19-vaccines-in-the-context-of-limited-supply},
}

@misc{10665-338849.sec-034.5,
  year = {2020},
  url  = {https://www.who.int/publications/i/item/who-WHO-values-framework-for-the-allocation-and-prioritization-of-covid-19-vaccination},
}
